| Tag | Content |
|---|
EnhancerAtlas ID | HS091-30524 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr20:31377380-31379400 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr20:31378020-31378039 | TGACCAGCAGAGGGAGGAC | + | 6.15 | | EWSR1-FLI1 | MA0149.1 | chr20:31379241-31379259 | TTTTCTTTCCTTCCTTTC | - | 6.4 | | EWSR1-FLI1 | MA0149.1 | chr20:31377834-31377852 | GGCAGGATTGAAGGAAGG | + | 6.59 | | Zfx | MA0146.2 | chr20:31377643-31377657 | CCCGCCTCGGCCTC | + | 6.01 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_61968 | chr20:31368997-31387215 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr20 | 31378676 | 31378947 | | chr20 | 31378388 | 31378478 | | chr20 | 31377734 | 31378287 |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH20I032790 | chr20 | 31377921 | 31378110 | | GH20I032791 | chr20 | 31379345 | 31382533 |
|
Enhancer Sequence | TTACACTCTT TCAACAAAGA TTTTTTTGGG GGCGGTGAGA ATGGAGTCTC ACTCTGTTGC 60
CCAGACTGGA GTGCAGTGGT GCGATCTTGG CTCACTGCAA CCTCCGCCTC CCAGGTTCAA 120
ACAATTCTCC TGCCTCAGCC TCCTGAGTGG CTGGGGTTAC AGGCACCTGC CACCGCACCC 180
TGCTAATATT TGCATTTTTA GTACAGACTG GGTTTCACCA TGTTGGCCAG GCTGGTCTCC 240
AACTCCTGAC CTCAGATGAT CCACCCGCCT CGGCCTCCCA GTGCTGGGAT TACAGGCGGG 300
AGCCACCACG CCTGGCCTCA ACAAAGATTT TAATCAGACA GACCTATCCT GTGATGGTCT 360
CTTAGAAGTA AATGTTAGTC CTACCCTCAG AGCCCTGAGA GAGGCTAAGT TAGGTGCCTA 420
AGGTCATTGG GCAAGTTGCA GCAGAAGCAA GCCAGGCAGG ATTGAAGGAA GGACTGTACA 480
TTCCTGGGAT TCAGCTCAAG CAGAGATTCT GTTTTTCCCA GGAATTGAGC TACCATGGGG 540
CCATTTGCCA TGAGCTAATT GAAGTTTCCC AAGGGCTACA ATAATATATT GGGTGTGGAG 600
TCTCCTTTGT AGGAGAGCCC CTGCATGCAG TTGCCTGCTG TGACCAGCAG AGGGAGGACA 660
AGTCCTGGGC CCATGCTGGC AGTGAGGCAG CTGCTTCCAG GGATGGGAGA GCAGTAACTC 720
AAGTGAAGGA AGATGGATTG TTTGCAATTG CTTTGCCCCA TCGAGACATA AAATGCACTT 780
TGCAAGATAG AGTCTGAGGC TAATACAATG CAGTGTGGGG CTGTCAGCAT TAGGGGATGA 840
GATGACAATA TGGGACCTGG GTCTGGCCTG GGCAAGTGCC TGCTCAGCAT GTGTACGCTG 900
TTTGGGTTGT ATTGGAGCTA TTGGGCGCTG GAACCAGCAC TTGTGTTGGA GCGGTTTCCC 960
CCCACCAGAG CCACAGTGTT TTCTCCCCAG TGGTGGTCAC ACCCCCATAT AGGAAATCAG 1020
GCATTCCGTG ATAAAATGGA GGTTTGCATG AGTGTGAGCA CTCTTTACGG AGACTAGAAC 1080
ATTCCCTGTG TCTTTCAGTT CCTTTTTTTT TTTAAGAGAT GAGGTCCTCA CTGTCACCCA 1140
GGCTGGAGTG CAGTGGCACT GTCTTGGCTC ACTGCAGCCT CAATCACCTG GGCTCAAGCA 1200
ATCCTTCTGC CTTAACAGAG CAGCTGAGAC TGCAGGTGCA CACCACTGTG TTTGGCTCTT 1260
AAAAGTTTTT GTAGAGATGG GGTCTTGCTG TGTTGTCCAG GCTAGTCGAA CTCCTGGGCT 1320
CAAGCGATCC TCTCAACTCC CACTCCCAAA GTGCTGGGAA TATAGGCCTG AGCCACTACG 1380
TCTGGCCTTT CAGTTCTGAT TAGCATCCCT GAATGGCCAT TTTCTCTCTC ACTGGCAACT 1440
CAGTCAGTTC ATGCTTGGTC CAGGGACTTG GTACATCAGG AGACTTGTGG AATATGGATT 1500
AAATCACAAG AACTAAAGTT AAATAATCAC AACAAGTGAA AGGTGCTGTG TCGAGCACTG 1560
TTTTCTAAAC ACATTCATTA GGTGAACTCA TTTTAATAAA AGGGTAAAGA GTAAACAATT 1620
ATCATGCTTA GGAAAGAAGG AATATGTGCA AACCCTCAAT GCTGGAGCAG CCACAGAGAA 1680
TATTAGGACT GAGCCTCAGG GGTCCACACC AGGGACACCT GCTTGGAAAA TGTATACAAA 1740
CACAGGGTTC GCCTAATTGC CTTCATTCAG AGTATCCTCC TTTTCCACAG TGGAAGTGTC 1800
GTACCTAACA AGGTTCTGGA TATCTGTGTG TTGAGACTCT GCCATTTCTA TTTTTCTGCT 1860
TTTTTCTTTC CTTCCTTTCA AATAGATGTC TGTGGACTTT ATCCCCAGGA ATGGTCTCTT 1920
GGTTAAAGTG TGTGAAAATC TTCTGCATCT GATGGACAAC ATTGTGATAG ACATGGCACC 1980
TGGGACACAC CTGTAGGTGG ATGTTGATGA TGTCTTTCTC 2020
|
